WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis ...

The decline of real-life slimming clubs is down to a variety of factors, says Kate. ‘Diets come in fads — at the moment, ...

WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the ...

Among them, WW International (WW), formerly known as WeightWatchers, hit a rough patch earlier this year, resulting in WW ...

WeightWatchers’ stock was surging after the company emerged from bankruptcy two months after it was announced.

Dan Haar: Ozempic and Wegovy are expensive. Connecticut wants to make its own cheaper version.

With new leadership and a Nasdaq relisting plan, the iconic brand is betting on women’s health and weight loss drugs to stage a comeback.

WeightWatchers on Tuesday named Dr. Kim Boyd as chief medical officer and said it was planning a new program to help women manage the transition into menopause and beyond, as part of its growth ...

WeightWatchers said its forthcoming menopause programme — which will deliver “tailored nutritional and behavioural strategies” — is a “strategic move to address a broader gap in healthcare”.

WeightWatchers completed its strategic reorganization process, naming Kim Boyd its Chief Medical Officer.